Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,030,798,719
+$172,742,817 QoQ
Shares Held
4,096,323
+3.8% QoQ
Ownership
0.232%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#46
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 8%
Shared 0%
None 92%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Mar 31, 2025CallValue
$0
CallShares
0
PutValue
$209,520
PutShares
1,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LPL Financial LLC holds $5,886,151,720 across 17 Drug Manufacturers - General names. ABBV ranks #3 (17.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,274,807 | $1,529,041,887 | |
| 2 | JNJ |
Johnson & Johnson
|
5,055,143 | $1,283,854,667 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
4,096,323 | $1,030,798,719 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,836,733 | $493,020,190 | |
| 5 | AMGN |
Amgen Inc
|
1,188,164 | $430,257,947 | |
| 6 | PFE |
Pfizer Inc
|
13,919,821 | $335,189,289 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,265,381 | $188,151,253 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
969,813 | $122,526,174 |
All Filings in ABBV
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,030,798,719 | 4,096,323 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $858,055,902 | 3,945,266 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $880,394,133 | 3,853,097 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $864,429,815 | 3,733,393 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $637,205,988 | 3,432,852 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $209,520 | 1,000 | Put | Sole | 2025-05-07 | |
| 2025-03-31 | $664,649,400 | 3,172,248 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $525,200,168 | 2,955,544 | Shares | Sole | 2025-02-11 | |
| 2024-12-31 | $408,710 | 2,300 | Call | Sole | 2025-02-11 | |
| 2024-12-31 | $2,701,040 | 15,200 | Put | Sole | 2025-02-11 | |
| 2024-09-30 | $524,863,133 | 2,657,804 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $440,002,314 | 2,565,312 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $445,019,622 | 2,443,820 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $389,889,177 | 2,515,901 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $363,784,805 | 2,440,526 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $307,221,181 | 2,280,273 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $366,033,525 | 2,296,753 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $346,954,367 | 2,146,862 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $273,072,658 | 2,034,667 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $299,904,280 | 1,958,111 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $323,257,066 | 1,994,060 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $264,235,672 | 1,951,519 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $195,947,688 | 1,816,517 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $187,397,928 | 1,663,689 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $179,882,526 | 1,662,193 | Shares | Sole | 2021-05-14 | |
| 2021-03-31 | $292,194 | 2,700 | Put | Sole | 2021-05-14 | |
| 2020-12-31 | $169,785,496 | 1,584,559 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $120,289,011 | 1,373,319 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $132,317,971 | 1,347,708 | Shares | Sole | 2020-08-13 | |
| 2020-06-30 | $245,450 | 2,500 | Put | Sole | 2020-08-13 | |
| 2020-03-31 | $91,978,548 | 1,207,226 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||